SI
ZYME icon

Sofinnova Investments’s Zymeworks ZYME Stock Holding History

Sofinnova Investments’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,610
Closed -$40.3K – 87
2026
Q1 		$40.3K Buy
+1,610
New +$38.1K ﹤0.01% 74
2022
Q1 		– Sell
-392,712
Closed -$6.44M – 79
2021
Q4 		$6.44M Sell
392,712
-17,907
-4% -$373K 0.38% 49
2021
Q3 		$11.9M Buy
+410,619
New +$13.7M 0.71% 34
2020
Q4 		– Sell
-151,902
Closed -$7.08M – 81
2020
Q3 		$7.08M Sell
151,902
-147,832
-49% -$5.08M 0.52% 31
2020
Q2 		$10.8M Buy
299,734
+249,745
+500% +$9.2M 0.68% 33
2020
Q1 		$1.77M Sell
49,989
-57,563
-54% -$2.36M 0.16% 55
2019
Q4 		$4.89M Sell
107,552
-80,886
-43% -$2.94M 0.35% 44
2019
Q3 		$4.67M Buy
188,438
+381
+0.2% +$9.55K 0.42% 45
2019
Q2 		$4.14M Buy
+188,057
New +$3.45M 0.38% 44

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Sofinnova Investments's ZYME Position: Q2 2026 in Review

Sofinnova Investments sold out of Zymeworks (ZYME) in Q2 2026, closing a stake of 1,610 shares — an estimated $40.3K sold.

Sofinnova Investments first reported a position in ZYME in Q2 2019 and held it in 9 quarters. The position peaked at $11.9M in Q3 2021. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Sofinnova Investments reported no remaining Zymeworks position as of Q2 2026 after selling out during the quarter.
  • Sofinnova Investments sold 1,610 Zymeworks shares in Q2 2026, an estimated $40.3K.
  • Sofinnova Investments first reported a position in Zymeworks in Q2 2019 and held it in 9 quarters.
  • Sofinnova Investments's Zymeworks position peaked at $11.9M in Q3 2021.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.